Close

Anti-CEA (Fl1-39) h(CD28-CD3ζ) CAR, pSBCAR1 (CAR-SB-LX0161)

Online Inquiry  Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sleeping Beauty (SB) transposon, a type of nonviral integrative vectors, provides an alternative to modify primary T cells. Creative biolabs has developed SB transposon CAR vector pSBCAR1 CEA (Fl1-39) h(28ζ), which is constructed for the engineering of T cells to target human CEA. The T cells are genetically modified through transduction with a nonviral vector expressing scFv of anti-CEA antibody linked to CD28 and CD3ζ signaling domains. And the vector product was designed for the treatment of Colon Cancer.

Specific Inquiry

  • Size:
  • Marker:
  • Form:
  Add to Cart

Details

  • Target
  • CEA
  • Targeting Cell Type
  • T cell
  • Targeting Diseases
  • Colon Cancer
  • Generation
  • Second
  • Vector Name
  • pSBCAR1
  • Vector Length
  • ~6kb
  • Vector Type
  • Sleeping Beauty (SB) transposon
  • Receptor Construction
  • scFv-CD28-CD3ζ
  • Discription of Signaling Cassetes
  • CD28
    CD28 (Cluster of Differentiation 28) is one of the proteins expressed on T cells that provide costimulatory signals required for T cell activation and survival. CD28 is the receptor for CD80 (B7.1) and CD86 (B7.2) proteins which are expressed on antigen-presenting cells (APC). CD28 modulates the primary TCR/CD3ζ signal in a different fashion than the late costimulatory elements OX40 and 4-1BB. CD28 enhances the expression of downstream regulators that impact on T-cell proliferation, death, differentiation, and effector functions. CAR+ T cells containing the CD28 endodomain showed strikingly enhanced sustained T cell activation, growth, survival. And CD28 results in a brightly expressed, stable receptor as the transmembrane domain. Including CD28 costimulatory domains in CARs led to enhanced anti-malignancy efficacy.
    CD3ζ
    CD3ζ, also known as T-cell receptor zeta, which together with T-cell receptor and CD3γ, δ, ε chain, forms the TCR-CD3 complex. ζ was expressed independently from the complex. The zeta chain plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. CD3-zeta, which contains 3 ITAMs, is the most commonly used endodomain component of CARs. It transmits an activation signal to the T cell after antigen is bound. CD3-zeta may not provide a fully competent activation signal and additional co-stimulatory signaling is needed. For example, chimeric CD28 and OX40 can be used with CD3-zeta to transmit a proliferative/survival signal, or all three can be used together.

Target

  • Clone
  • Fl1-39
  • Host
  • Mouse
  • Target Species
  • Human
  • Gene Name
  • CEA
  • Synonyms
  • CEA; CD66e;

Customize Your CAR Products

Cannot find the desired product? Don't worry, just try our online CAR and CAR cell customizing system, which offers full options to meet all unique needs, including but not limited to conventional or unconventional CAR constructs, as well as a variety of vectors and cells. The customization process can be completed with just a few simple clicks, please feel free to try it out.
CAR and CAR Cell Customizing System
  • Published Data
CAR scFv data ELISA

Fig.2 The CEA binding activity of serially diluted 45scFvLCHα was evaluated by a sandwich ELISA.

CAR Construction : Latest CAR Construction

Fig.2 The CEA binding activity of serially diluted 45scFvLCHα was evaluated by a sandwich ELISA.

Antigen binding activity of isolated 45scFvLCHα.

ARAKAWA, F., HARUNO, M., KUROKI, M., KANDA, H., WATANABE, T., MISUMI, Y., & MATSUOKA, Y. (1993). Construction and Expression of Two Mouse—Human Chimeric Antibodies with High Specificity and Affinity for Carcinoembryonic Antigen. Hybridoma, 12(4), 365-379.

CAR scFv data Inhibit

Fig.3 Competitive inhibition assays of chimeric antibodies against parental MAbs for CEA binding in SPEIAs using purified biotinylated CEA.

CAR Construction : Latest CAR Construction

Fig.3 Competitive inhibition assays of chimeric antibodies against parental MAbs for CEA binding in SPEIAs using purified biotinylated CEA.

Fl 1-39 was dried onto wells of 96-well plates.

ARAKAWA, F., HARUNO, M., KUROKI, M., KANDA, H., WATANABE, T., MISUMI, Y., & MATSUOKA, Y. (1993). Construction and Expression of Two Mouse—Human Chimeric Antibodies with High Specificity and Affinity for Carcinoembryonic Antigen. Hybridoma, 12(4), 365-379.

CAR scFv data ELISA

Fig.4 Reactivity of mouse MAbs (Fll-35 and Fll-39) with CEA and CEA-related antigens.

CAR Construction : Latest CAR Construction

Fig.4 Reactivity of mouse MAbs (Fll-35 and Fll-39) with CEA and CEA-related antigens.

A SPEIAs using antigen-coated plates and a biotinylated goat anti-human y-chain antibody or a biotinylated horse anti-mouse IgG(H+L) antibody.

ARAKAWA, F., HARUNO, M., KUROKI, M., KANDA, H., WATANABE, T., MISUMI, Y., & MATSUOKA, Y. (1993). Construction and Expression of Two Mouse—Human Chimeric Antibodies with High Specificity and Affinity for Carcinoembryonic Antigen. Hybridoma, 12(4), 365-379.

CAR scFv data FCM

Fig.1 Detection of the expressed F39scFv/CIR receptors in the transfectoma by flow cytometry.

CAR Construction : Latest CAR Construction

Fig.1 Detection of the expressed F39scFv/CIR receptors in the transfectoma by flow cytometry.

Cell surface expression of the F39scFv CIR receptor protein in the transfectoma was demonstrated by FACS,

Arakawa, F., Shibaguchi, H., Xu, Z. H. O. N. G. W. E. I., & Kuroki, M. (2002). Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity. Anticancer research, 22(6C), 4285-4289.

More Published Data More Published Data

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CEA (Fl1-39) h(CD28-CD3ζ) CAR, pSBCAR1 (CAR-SB-LX0161). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.